← The Signal Archive
The Signal

The Market Is Selling AI. Drugmakers Are Buying It

Seven big drugmakers say AI has cut early discovery time by as much as half, Reuters reports. Healthcare got sold with the AI names Thursday, but it's a buyer of the technology, and time saved in the lab comes back as protected sales.

By Brad Roth··7 min read·Read on Beehiiv →
The Market Is Selling AI. Drugmakers Are Buying It

Seven big drugmakers say AI has cut early discovery time by as much as half, Reuters reports. Healthcare got sold with the AI names Thursday, but it's a buyer of the technology, and time saved in the lab comes back as protected sales.

Brad Roth
November 20, 2026

TL;DR

  • Anthropic closed its first day 17% above its $83 offer and is down more than 6% before the bell. Nasdaq 100 futures are off 1.66%, and the VIX touched 30.04, its highest since March 30, per Cboe.

  • Investors went to bonds instead. The ten-year is back under 5% at 4.969%, down 8.1 basis points.

  • Seven large drugmakers told Reuters AI has cut the time to get new molecules into trials by as much as half. Healthcare fell 2.05% Thursday anyway.

THOR Signals · From the same desk
A nightly desk note after the close, white-label commentary you can send to your clients, and a systematic read on any name they hold, three horizons, with the price where each read turns.
See it at thorsignals.com →

Market Pulse

Futures as of 7:13 AM ET, commodities as of 7:18 AM ET, yields as of 7:25 AM ET, currencies as of 6:52 AM ET

  • S&P 500 futures are down 0.77% at 7,141.75.

  • Nasdaq 100 futures are down 1.66% at 26,160.00.

  • Dow futures are down 0.15% at 49,108.00.

  • Russell 2000 futures are down 0.32% at 2,654.70.

The S&P 500 fell 1.96%, the Dow 2.18%, the Nasdaq 100 2.19% and the Russell 2000 2.18%. All eleven sectors closed lower. Energy held up best at minus 0.65%, and consumer discretionary was worst at minus 2.79%. Overseas, Nikkei futures are down 2.46% and DAX futures 2.11%.

  • West Texas is $82.28, down 0.19%. Brent is $91.69, down 0.32%.

  • Gold is $3,575.57, down 2.98%. Silver is $42.14, down 5.01%, and copper is $5.53, down 1.78%.

  • The ten-year is 4.969%, down 8.1 basis points. The two-year is 4.709%, down 7.0, and the 30-year is 5.354%.

  • Euro/dollar is 1.0961 and the dollar buys 158.83 yen, down 0.54%. The VIX is 29.50. Bitcoin is $61,557, down 0.69%.

  • The Fed's Waller speaks at 8:25. The University of Michigan's final November survey lands at 10, with one-year inflation expectations seen at 4.3% from 4.7%. Fed Governor Cook speaks at 12:15.

THOR Risk Gauge

Cautious. The VIX is near 30 and Nasdaq 100 futures are down 1.66% after a session when no sector closed higher. Markets still price a December hike, per CME FedWatch. Bonds bid and gold sold at once means investors are raising cash, not picking spots.

The THOR View

This week's selling has a target, the companies spending on AI and the ones selling them the gear. Thursday's IPO didn't answer the question investors keep asking, which is whether the data center spending pays back. Drugmakers are the customer in that trade. They don't borrow billions to pour concrete and buy chips. They pay for access to the models, so their return on AI doesn't hang on whether someone else's data center earns its keep.

Reuters reported this morning that the return is already showing up. Seven of the largest drugmakers say AI has cut the time to design new molecules and get them into trials by as much as half. Novo Nordisk says it went from about eight design rounds to three, each four weeks instead of eight. Time is the costliest input in a drug, which takes 10 to 15 years and billions of dollars to bring to market, per the industry group PhRMA. Once a molecule is patented, every year in development uses up a year of protection. So when Sanofi says AI let it skip a dosing study and save at least a year, that year comes back as a year of protected sales.

Thursday's selling didn't sort the buyers of AI from the builders. Healthcare fell 2.05%, more than the S&P 500, right alongside the companies whose AI bills are the worry. Higher borrowing costs hit the builders first, because they fund the build with debt. A drugmaker using a tool that's already paying back faces a smaller version of that risk, and the ten-year at 4.969% makes its steady cash worth more. The healthcare holding is set up to collect that gap as the market starts pricing it.

This week on Behind the Ticker
Nvidia's Picks and Shovels, Without Owning Nvidia
With Joe DeYonker, PurePlay ETFs
Watch the episode →
Prefer audio? Spotify · Apple Podcasts

Signal Watch

THOR Index Rotation — As of 11/19/26

Index

Weight

Signal

Status

Dow (DIA)

49.7%

Risk-On

🟢

S&P 500 (SPY)

49.7%

Risk-On

🟢

Nasdaq 100 (QQQ)

0.0%

Risk-Off

🔴

Cash + T-Bills (BIL)

0.6%

—

—

Dow futures are down just 0.15% against 1.66% for the Nasdaq 100. Amgen and UnitedHealth rank among the Dow's highest-priced shares, so drugmakers and insurers count for more there than in the S&P 500.

THOR Low Volatility — As of 11/19/26

Sector

Weight

Signal

Status

Utilities (XLU)

14.4%

Risk-On

🟢

Consumer Staples (XLP)

14.1%

Risk-On

🟢

Financials (XLF)

14.1%

Risk-On

🟢

Healthcare (XLV)

14.0%

Risk-On

🟢

Real Estate (XLRE)

13.9%

Risk-On

🟢

Consumer Disc (XLY)

13.7%

Risk-On

🟢

Materials (XLB)

13.3%

Risk-On

🟢

Energy

0.0%

Risk-Off

🔴

Industrials

0.0%

Risk-Off

🔴

Technology

0.0%

Risk-Off

🔴

Cash + T-Bills (BIL)

2.5%

—

—

Utilities fell 1.24% and real estate 1.70% Thursday, the two holdings priced most directly off bond yields, as the ten-year slid. Healthcare's 2.05% drop came a day before this morning's report on its labs.

THOR AdaptiveRisk Dynamic — As of 11/19/26

Holding

Ticker

Weight

AGF U.S. Market Neutral Anti-Beta

BTAL

9.8%

Energy Select Sector SPDR

XLE

9.3%

Simplify Interest Rate Hedge

PFIX

6.9%

Roundhill Magnificent Seven

MAGS

6.8%

Walmart

WMT

6.7%

Eli Lilly

LLY

5.9%

VanEck Semiconductor

SMH

4.9%

Southern Company

SO

4.7%

Costco Wholesale

COST

4.2%

iShares 3-7 Year Treasury Bond

IEI

3.9%

Other (16 holdings)

—

36.9%

Seven of every ten dollars here are in stocks, and bonds and alternatives make up about a fifth together. Eli Lilly, one of the seven drugmakers in the Reuters report, is the largest healthcare name.

THOR Conservative Risk Dynamic — As of 11/19/26

Holding

Ticker

Weight

WisdomTree US Dollar Bullish

USDU

35.5%

Invesco Diversified Commodity Strategy

PDBC

11.7%

iShares MSCI USA Min Vol Factor

USMV

9.6%

iShares 3-7 Year Treasury Bond

IEI

9.3%

AGF U.S. Market Neutral Anti-Beta

BTAL

6.6%

Energy Select Sector SPDR

XLE

6.1%

Health Care Select Sector SPDR

XLV

3.7%

Roundhill Magnificent Seven

MAGS

3.7%

VanEck Semiconductor

SMH

3.1%

Microsoft

MSFT

2.3%

Other (4 holdings)

—

6.6%

Cash

—

1.9%

A fund that gains when the dollar rises takes about 35 cents of each dollar, ahead of commodities, Treasuries and a stock slice of about a third. Healthcare shows up here too, through the sector fund.

One Thing to Watch

Whether healthcare trades apart from the Nasdaq 100 after the open. The Reuters report landed before the bell, so if the sector still falls in step with chips, the market isn't separating AI's buyers from its builders yet. A gap in healthcare's favor would be the first sign that it is.

Fifteen minutes with Brad
The framework behind this note, the index history underneath it, and an honest read on where it fits in your allocation. No deck.
Book a time →

Brad Roth / CIO, THOR Financial Technologies

This content reflects the opinions, analyses, and research of THOR Financial Technologies as of the date published. It is provided for informational and educational purposes only and does not constitute investment advice and should not be relied upon as the basis for any investment decision. Past performance doesn't guarantee future results, and all investments involve risk. For more information, please go to: thorft.com

Read the original on Beehiiv
Full formatting, links, and subscriber features available on the Beehiiv platform.
Read on Beehiiv →
Behind the Ticker Podcast

🎙️ Behind the Ticker Podcast

ETF industry conversations with Brad Roth — strategy, structure, and the stories behind each fund.

Listen

Get The Signal Every Morning

Brad Roth's daily market brief — systematic signals, ETF positioning, and what the data is actually showing. Free to subscribe.

Subscribe on Beehiiv